4/6, 12:31 PM (Source: TeleTrader)
more TeleTrader news

Catalent to boost Moderna jab output in US - report

Catalent Inc., a contract drug manufacturer, reached an agreement with Moderna Inc., committing to double the production of Moderna's COVID-19 vaccine in its Indiana plant, The Wall Street Journal reported on Tuesday, citing sources familiar with the matter.

The agreed-upon upgrade will increase Moderna's output by some 80 million vials a year, while the new doses will be available starting next month, the outlet explained.

Moderna's shares rose slightly in the premarket, gaining 1.11% to go for $131.35.

Breaking the News / BU